TRAM2 and neoplasm: Previous studies have also shown that enhancer-driven TRAM2 activation is correlated with the expression and activation of the co-transcriptional factor YAP in nearly all tumor types, facilitating specific programs for cell proliferation, migration, and invasion during tumorigenesis [35,36], and high TRAM2 expression correlates with poor patient survival probability [35].